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Summary
Objective. Analysis of the initial surgical approach in patients with localized rhabdomyo-
sarcoma, enrolled in Italian Studies (1979-2003).
Methods. Surgical records of 587 patients were evaluated. As primary surgery, the exci-
sion was recommended if microscopically complete, otherwise biopsy was preferable.
Results. The initial biopsy, performed in almost 50% of patients in RMS-79 protocol, has
been adopted more often in the protocol RMS-88 and 96. However, the “complete resec-
tion” rate has remained quite stable through the years, as well as the percentage of micro-
scopic residue. The macroscopic residue disease has been more important in RMS-88
study than in RMS-96. Most GUnBP tumors and about 10% of HNnPM and other site we-
re successfully excised. A complete resection was rarely attempted in orbit, HNPM, and
GUBP sites; regarding the extremities tumors, 62.5% of patients in RMS-79 study un-
derwent a complete conservative excision, while most patients in RMS-88 and 96 un-
derwent biopsy only.
Conclusion. Initial surgical approach has become more conservative, avoiding mutila-
tions, but the incomplete resection rate is still high. A satisfactory initial excision was ob-
tained in GUnBP RMS (mainly paratesticular). In other localizations the feasibility of a
complete resection was slightly better for T1a RMS; a careful preoperative evaluation is
always necessary.
Riassunto
Scopo. Analisi dell’approccio chirurgico iniziale in pazienti con rabdomiosarcoma loca-
lizzato (Studi Italiani 1979-2003).
Materiali e Metodi. Valutazione dei dati chirurgici di 587 pazienti. L’exeresi iniziale era
raccomandata se microscopicamente completa, altrimenti la biopsia era preferibile.
Risultati. La biopsia iniziale, eseguita nel 50% dei pazienti del protocollo RMS-79, è
stata adottata in un numero maggiore di pazienti nei protocolli successivi. Tuttavia, il
tasso di resezione incompleta si è mantenuto alto, come pure quello dei residui micro-
scopici. La percentuale di residui macroscopici è stata maggiore nel protocollo RMS-
88 rispetto a quella del 96. La maggior parte dei tumori GUnVP e circa il 10% di quelli
TCnPM e altre sedi è stata asportata completamente. Per quanto riguarda i tumori
dell’orbita, TCPM e GUVP, l’exeresi radicale è stata tentata raramente. Nel protocollo
RMS-79, il 62,5% dei pazienti con tumore agli arti ha ottenuto una resezione radicale;
nei successivi, la maggior parte dei pazienti è stata sottoposta solo a biopsia iniziale.
Conclusioni. La chirurgia iniziale è diventata più conservativa, evitando le mutilazioni,
ma le exeresi incomplete sono ancora numerose. Un’asportazione iniziale soddisfacente
è stata ottenuta nei RMS GUnVP (prevalentemente paratesticolari). In altre localizza-
zioni le exeresi radicali sono state più frequenti nei RMS T1a; un’attenta valutazione
pre-operatoria è sempre necessaria.
Introduction
RMS account for approximately half of all sarcomas in
childhood and represent about 6% of all pediatric mali-
gnancies 1.
RMS arise from immature mesenchymal cells, and can
be found anywhere in the body, including those sites
where normally there are no striated muscles 2. The hi-
stological classification divides them into three main
groups: those with favorable prognosis (botryoid and
spindle cells RMS), those with intermediate prognosis
(embryonal RMS), and those with unfavorable progno-
sis (alveolar RMS). Following an international defini-
tion, primary sites are divided into: head-neck parame-
ningeal (HNPM), head-neck non parameningeal
(HNnPM), orbit, genito-urinary bladder prostate
(GUBP) and genito-urinary non bladder prostate
(GUnBP) (paratesticular site, vagina, uterus), extremi-
ties (limbs with shoulder girdle and thigh), other sites
(trunk, abdominal wall, intrathoracic and intra-abdomi-
nal sites, pelvis, perineal and paravertebral regions).
The clinical features depend mainly on the site of the
tumor origin, its extension to contiguous organs or tis-
sues and the presence of metastases.
In non-metastatic RMS, all the cooperative studies ha-
ve demonstrated the crucial role of disease extent at
diagnosis in predicting survival, as defined by the cli-
nical TNM and surgical Intergroup Rhabdomyosarco-
ma Study (IRS) system. Other important prognostic
factors are primary site, histology, and local control ob-
tained during treatment.
These tumors are the object of many multi-institutional
clinical trials in Europe and the USA, and their treat-
ment is multimodal, including surgery (S), radiothe-
rapy (RT) and chemotherapy (CT) in order to achieve
the local control and to eradicate both micro- and ma-
croscopic metastases 2. The clinical pattern of RMS and
the good response to CT explain the less aggressive
surgical management adopted in children, comparing it
with that in adults. Surgery represents an important
step in the therapeutic plan of RMS, and a correct ini-
tial approach increases the possibility of a complete re-
mission.
The purpose of this study was the analysis of the initial
surgical approach in patients with non-metastatic tu-
mors, enrolled in the National Cooperative Studies of
the Italian Association of Pediatric Hematology and
Oncology (AIEOP RMS-79, 88 e 96). The compliance
to the protocol guidelines was evaluated, and the re-
sults obtained are discussed taking into account the
main clinical factors.
Materials and methods
From October 1979 to December 2003, 587 valuable
patients were enrolled from 35 Italian Pediatric Onco-
logy and Pediatric Surgery Centers: 132 in RMS-79
study, 215 in RMS-88 and 240 in the ongoing RMS-96.
Patients’ ages ranged from 0 to 18 years (median 61.8
months), but until 1996 it varied between 0 and 16
years. The sites were the following: orbit 74, HNnPM
64, HNPM 114, GUBP 61, GUnBP 98, extremities 53,
other sites 123.
Patients were staged according to the TNM clinical sy-
stem: T1 indicated a neoplasm confined to the anato-
mic site of origin, T2 a tumor involving contiguous or-
gans or structures, or with neoplastic effusion to adja-
cent serous cavity (pleural or peritoneal). T1 and T2 tu-
mors were also divided, on the basis of size, into sub-
stages “a” and “b”, indicating tumors ≤ 5 cm and tu-
mors > 5 cm, respectively. Tx was used when the mini-
mal required characteristics to define the primary tu-
mor were unknown. As to lymph node involvement, N0
indicated no clinical involvement, N1 extension to re-
gional nodes and Nx was used when the clinical invol-
vement was unknown. Similarly, M0 indicated absence
of distant metastases, M1 disseminated disease, and
Mx absence of data.
The post-surgical staging system, used in all the studies
and proposed by the IRS, was based on the results of
the initial surgical approach: Gr.I - localized tumor, mi-
croscopically resected and no lymph node involve-
ment; Gr.II - tumor grossly resected, but with micro-
scopic residue +/- regional lymph node involvement;
Gr.III - biopsy only or excision with macroscopic-resi-
due disease; Gr.IV - distant metastases at diagnosis
The multimodal treatment, recommended in the 3 pro-
tocols, has not substantially changed over the years. An
initial excision was indicated only when it could be mi-
croscopically complete and without major anatomic,
functional mutilations, such as orbital exenteration,
head-neck dissection, permanent colostomy, ileostomy
or urinary diversions, cystectomy, prostatectomy, hy-
sterectomy, limb amputation, resection of muscle grou-
ps or neurovascular structures with functional impair-
ment. The tumors had to be excised surrounded by a
layer of normal tissue and without rupture. Excisions
with microscopic or macroscopic residue,  requiring hi-
gh dose CT and RT, had to be avoided.
If a complete excision was not feasible, the suggested
option was a surgical biopsy in order to obtain a dia-
gnosis (tru-cut biopsy was accepted only for selected
cases, and the fine-needle aspiration biopsy was di-
scouraged). The delayed surgery had to be planned af-
ter the neoadjuvant CT.
Since 1990, the primary re-excision (PrE) has been uti-
lized for those cases in which residual disease was su-
spected after an initial excision; it consisted in the re-
moval of the area of the previous operation before other
treatments, with the aim to obtain a radical excision
without mutilations. This procedure was recommended
particularly for trunk and extremities and in children
below age 3 years , in whom local treatment cannot be
generally completed with RT. Particular surgical re-
commendations were addressed to the paratesticular
RMS. These had to be removed by a radical inguinal
orchiectomy, with resection of the entire spermatic
cord: if the scrotum appeared to be involved, a hemi-
scrotectomy and the exploration of the inguinal lymph
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nodes had to be associated. The regional lymph node
biopsy was recommended in all sites only if the pri-
mary tumor had been removed. Moreover for extremity
RMS, the biopsy was always recommended, because of
the high rate of lymph node involvement. In paratesti-
cular RMS, the retroperitoneal lymph node exploration
was suggested only in case of a suspected swelling at
the imaging evaluation.
Results
An initial excision was attempted in 260/587 patients:
67/132 (50.8%) in the RMS-79 Study, 90/215 (41.9%)
in the RMS-88, 103/240 (42.9%) in the RMS-96. In the
first protocol, about 50% of patients underwent exci-
sion and about 50% just a biopsy; in the following pro-
tocol, the rate of initial biopsy raised. The excisions
were largely conservative: only in the RMS-79 did two
patients undergo a mutilating excision, which was radi-
cal in one case and left microscopic residue in the
other. During the last two studies no mutilating initial
excisions were performed.
In RMS-79, apart from the 2 patients who underwent
an initial mutilating excision, 65 had an initial surgical
approach to get a complete resection, but only in 31/65
(47.7%) this was successful; in 52.3% of patients, resi-
dues were left (microscopic in 16/65 and macroscopic
in 18/65).
In RMS-88 an initial excision was attempted in 90/215
patients (41.9%), with completeness achieved in 29
(32.2%), 7 of whom with a PrE; in 25/90 patients mi-
croscopic residues were left and in 36/90 they were ma-
croscopic.
In RMS-96, the initial excision was carried on in
103/240 patients (42.9%). It was radical in 48/103 cases
(46.6%), through a PrE in 23, resulting in microscopic
residue in 37 and with macroscopic residue in 18.
Overall, during the 3 Studies considered, less than 50%
of the patients who underwent an initial excision effec-
tively obtained complete resection of the neoplasm.
Considering the whole population, only 108/587 cases
(18%) obtained the local control through complete ini-
tial surgery (Tab. I).
ROLE OF TUMOR SITE
Considering the tumor site, the complete excisions in
the RMS-79 study was 31/132 (24%): 1/10 (10%)
HNnPM, 2/11 (18.2%) GU BP, 14/19 (73.7%) GUnBP,
10/16 (62.5%) extremities, 4/30 (13.3%) other sites.
In RMS-88, the microscopically-complete resections
were 29/215 (14%); 22/29 GUnBP tumors (75.9%) ob-
tained a complete excision, while the other sites had
lower percentage of radical excision: orbit 2/22 (9.1%),
HNnPM 2/28 (7.1%), extremities 1/14 (7.1%), other si-
tes 2/53 (37.7%). None of the HNPM or BP RMS had
a complete excision.
In RMS-96, an initial complete excision was obtained
in 48/240 cases (20%): 2/26 HNnPM (7.7%), 40/50
GUnBP (80.0%), 2/23 extremities (8.7%), 4/40 other
sites (10.0%) (Tab. II).
ROLE OF TUMOR SIZE AND INVASIVENESS
The results of the initial surgery on the basis of tumor
dimensions and local invasiveness (T in the TNM sy-
stem) were evaluated only in the RMS-96 study.
Of the 240 patients enrolled, 121 had tumors ≤ 5 cm
and 119 tumors > 5 cm. Seventy patients (58.3%) with
≤ 5 cm tumors underwent an initial excision, and 34
(48.6%) obtained a complete resection. The group in-
cluded mostly paratesticular tumors and two cases with
tumors of extremities.
In the group of > 5 cm tumors, 33 patients (27.7%) un-
derwent an initial excision, which was eventually com-
plete in 14 (42.4%). The tumors were mostly GUnBP,
and in three patients they were intra-thoracic, intra-ab-
dominal and involving the neck (Tab. III).
In the group of 48 patients who underwent a complete
excision, a PrE was performed in 24: 19/24 had ≤ 5 cm
tumors, and 18/24 cases were paratesticular (75%);
9/18 underwent a hemiscrotectomy because a trans-
scrotal surgical approach had been conducted as a first
operation: the histology did not demonstrate any evi-
dence of residue or scrotal infiltration.
Analyzing the tumor invasiveness, 113 patients had T1
and 127 T2 tumors. Sixty-seven patients (59.3%) with
T1 tumors underwent an initial excision that was com-
plete in 35 (52.2%). Thirty-six patients (28.3%) with
T2 tumors had an excision, which was radical in 13
Tab. I. Initial surgical approach (October 1979-December 2003).
RMS-79 RMS-88 RMS-96 Total
132 215 240 587
Biopsy 65 125 137 327
Conservative excision 65 90 103 258
Complete (after PrE) 31 29 (7) 48 (23) 108 (30)
Microscopic residue 16 25 37 78
Macroscopic residue 18 36 18 72
Mutilating excision 2 — — 2
Complete 1 — — 1
Microscopic residue 1 — — 1
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(36.1%). It is important to note that all the neoplasms
excised in HNnPM, extremities and other sites were
“not invasive” (T1), while among the 13 completely
excised “invasive” tumors, 11 were paratesticular (Tab.
IV).
INITIAL BIOPSY
Regarding the 137 patients in the RMS-96 study who
underwent an initial biopsy (Tab. V), 117 required sur-
gery; in 18 the biopsy was carried on through a “tru-
cut” and in 2 through a fine needle aspiration biopsy
due to an emergency situation.
Discussion
Since the introduction of multimodal therapy for the
treatment of RMS, the role of surgery has been deeply
modified. The surgeon does not have to make any effort
to remove the tumor initially, but has a role in a com-
plex treatment program, alongside the pediatric onco-
logist and the radiotherapist.
The initial surgery should be planned only if microsco-
pic residues are not left in the bed of the resection, and
the procedure is not mutilating. It is very well known
that non radical excisions do not have true advantages
in the outcome of the disease and those with microsco-
pic residues make treatment more difficult due to the
absence of a measurable target.
The progress of the surgical approach, as demonstrated
in literature, is also evident in the surgical data of the
Italian Studies, especially those of RMS-96.
The initial surgical approach has become more conser-
vative, with the progressive reduction in  the number
of excisions with macroscopic residual diseases in the
three Italian Studies. Debulking procedures are discou-
raged for their high intra-operative risk, and because
they do not offer advantages in term of results compa-
red to a simple biopsy.
The rate of excision with microscopic residual disease
is instead still relevant, even in the last study. While in
particular sites, such as HNPM or GUBP, the biopsy is
inevitable, for some other sites, such as limbs, HNnPM
and trunk, the feasibility of a complete resection has
been over-estimated: the choice between excision or
biopsy is based on clinical-radiological findings, but
might also be influenced by the surgeon’s skills and the
desire to remove immediately the tumor. In these sites
the excision at diagnosis may develop into microscopic
residual disease and the patients are necessarily given
RT and CT. In this situation the possibility to perform a
PrE has to be taken into account to obtain or  confirm
the radicality of the operation, without mutilations.
This procedure, introduced by Hays at the end of 80s 3
Tab. II. Complete excisions by tumor site.
RMS-79 RMS-88 RMS-96 Total
Orbit 0/23 2/22 0/29 2/74
HNnPM 1/10 2/28 2/26 5/64
HN PM 0/23 0/43 0/48 0/114
GU BP 2/11 0/26 0/24 2/61
GUnBP 14/19 22/29 40/50 76/98
Extremities 10/16 1/14 2/23 13/53
Other Sites 4/30 2/53 4/40 10/133
Total 31/132 29/215 48/240 108/587
Tab. III. Complete excisions by tumor size (Protocol RMS-96 up
to December 2003).
≤ 5 cm ≥ 5 cm Total
Orbit 0/13 0/0 0/13
HNnPM 1/12 1/2 2/14
HN PM 0/1 0/4 0/5
GU BP 0/2 0/3 0/5
GUnBP ¢ 28/28 10/10 38/38
GUnBP ª 1/5 1/3 2/8
Extremities 2/6 0/2 2/8
Other Sites 2/3 2/9 4/12
Total 34/70 14/33 48/103
Tab. IV. Complete excisions by tumor invasiveness (Protocol
RMS-96 up to December 2003).
T1 T2 or Tx Total
Orbit 0/11 0/2 0/13
HNnPM 2/11 0/3 2/14
HN PM 0/0 0/5 0/5
GU BP 0/2 0/3 0/5
GUnBP ¢ 27/27 11/11 38/38
GUnBP ª 2/7 0/1 2/8
Extremities 2/6 0/2 2/8
Other Sites 2/3 2/9 4/12
Total 35/67 13/36 48/103
387
INITIAL SURGERY FOR LOCALIZED RMS
and progressively developed in the last 15 years, has
improved the results of primary surgery in many cases,
both in the RMS-88 and RMS-96. It has allowed radi-
cality in those cases in which the mass had been remo-
ved without following the classic oncologic criteria,
either because the lesion had been considered benign
(very usual in adolescents and young adults) and also
because the patient had to be treated for an emergency
situation, such as torsion of the testis, through a tran-
scrotal approach. The analysis emerging from our ex-
perience and the data of the literature widely confirm
the usefulness of PrE 4.
When the primary surgical operation leaves microsco-
pic residues and a PrE is not feasible, CT and RT must
be given at the usual doses.
Patients in Gr.I, in whom the tumor has been removed
without microscopic residue, at diagnosis or within 6
weeks with a PrE, are at lower risk of developing rela-
pse and have a better prognosis, in terms of overall sur-
vival and event free survival.
The tumor site has been the most important factor to
predict a possible complete resection. On the basis of
our experience, only for paratesticular tumors, is a pri-
mary complete resection safely feasible. In the RMS-
96 Study, only 48 out of 103 initial resections planned
(46.6%) had been radical, and in 38/48 cases (79.2%)
the tumor was paratesticular. This site is considered the
most favorable for a radical excision and also for a PrE,
in case of possible residue on the tumor bed. The local
relapse observed in one patient who had a first opera-
tion through a scrotal incision and a PrE with resection
of the vaginal layer, without performing the hemiscro-
tectomy, provides evidence fact that a PrE with resec-
tion of all the soft tissues belonging to the testis is man-
datory 5. Hemiscrotectomy is always recommended;
however, recent reports question its usefulness in case
of a radical transcrotal incision 6 7. Larger series are
needed to confirm these data.
The rate of complete resections has been moderately
better in T1a tumors, comparing them with those with
T2b tumors, especially for the lesions occurring in
limbs and in other sites. In our series, a resection was
carried on in 58.3% of patients with ≤ 5 cm tumors, and
it resulted radical in half of these patients; in larger tu-
mors, the resection, attempted in 27.7% of cases only,
resulted complete in a very low percentage. Similar re-
sults have been obtained, if we consider the T-status:
51.3% of patients with T1 tumors underwent a resec-
tion, which resulted complete in 50% of them; the re-
section, performed in 28.3% of patients with invasive
tumors, was radical in 1/3 of the cases.
In cases in which a complete excision is not feasible,
the biopsy should be the best choice; a delayed surgery
is preferable, after the shrinkage of the tumor obtained
with CT. At that time a more aggressive surgical ap-
proach is encouraged, if necessary, to achieve local
control.
In our experience a biopsy was carried on at diagnosis
in 80% of patients: this approach was favored by the
impossibility to remove the lesion localized in some
specific sites, such as HNPM, GUVP, thorax and abdo-
men, and by the awareness that an incomplete procedu-
re would not have improved the outcome compared
with a simple biopsy.
The biopsy must provide a significant quantity of tis-
sue, to allow the histological diagnosis and the cytoge-
netic-biomolecular studies, which recently have been
gaining more importance for the diagnosis and treat-
ment. Tru-cut biopsies are rarely accepted, since they
provide small tissue specimen, inadequate for the va-
rious studies requested. They may be done in specific
clinical, serious situations. Tru-cut biopsies have obtai-
ned good results in the series described by Willman and
Hugosson 8 9. These results are not confirmed in our ex-
perience. Fine needle aspiration biopsies are not re-
commended. This technique may recognize a mali-
gnant lesion, but does not identify the histological sub-
group 10; nevertheless some studies are describing suc-
cessful results 11.
The local treatment of RMS is problematic: on one
hand it is necessary to limit permanent damage, parti-
cularly important in growing children; on the other, a
complete removal of the tumor is required to avoid re-
lapses. The initial surgical approach has become more
conservative in the last few years, decreasing the num-
ber of mutilating operations and excisions with macro-
Tab. V. Biopsies on the basis of site and technique employed (Protocol RMS-96 up to December 2003).
FNAB* Tru-cut Incisional biopsy Total
Orbit 1 15 16/29
HNnPM 1 11 12/26
HN PM 7 36 43/48
GU BP 2 17 19/24
GUnBP 4 4/50
Extremities 1 2 12 15/23
Other Sites 1 5 22 28/40
Total 2 18 117 137/240
* FNAB: fine-needle aspiration biopsy
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scopic residue. However, excisions with microscopic
residue are still a problem, probably due to over-esti-
mation of the feasibility of a complete resection. In the
past, various scores systems have been proposed to un-
derstand whether a radical excision was possible or not,
based on tumor site, size and invasivity 12. If we consi-
der our results, the tumor site is the most important fac-
tor to predict the possibility of a complete excision:
only the paratesticular site has allowed a higher num-
ber of radical excisions. Tumor size and invasiveness
must be taken into account in case of lesions of
HNnPM, trunk, limbs and other sites (intrathoracic, in-
trabdominal). Surgical biopsy is the best initial surgical
procedure for most tumors, and in particular for orbit,
HNPM and GUVP RMS. The possible suggestions on
the basis of our experience are summarized in Figure 1.
In the future the prognosis will improve if the primary
surgical approach is chosen with accuracy, and if there
is a deeper collaboration between oncologists, ra-
diotherapists and pediatric surgeons (also those with
specific expertise, such as maxillo-facial surgeon, uro-
logist, plastic surgeon, ENT surgeon, orthopedist),
whose main target is to make the best decisions in
terms of treatment.
Fig. 1. Suggested initial surgical approach.
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GU BP and Vagina
Paratesticular Excision
HNnPM
Extremities
Other Sites
Decision on the basis of tumor size and T-Status
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